These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 26974154)

  • 1. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation.
    Palanichamy JK; Tran TM; Howard JM; Contreras JR; Fernando TR; Sterne-Weiler T; Katzman S; Toloue M; Yan W; Basso G; Pigazzi M; Sanford JR; Rao DS
    J Clin Invest; 2016 Apr; 126(4):1495-511. PubMed ID: 26974154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
    Wang Z; Medrzycki M; Bunting ST; Bunting KD
    Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis.
    Tran TM; Philipp J; Bassi JS; Nibber N; Draper JM; Lin TL; Palanichamy JK; Jaiswal AK; Silva O; Paing M; King J; Katzman S; Sanford JR; Rao DS
    Leukemia; 2022 Jan; 36(1):68-79. PubMed ID: 34321607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL.
    van der Linden MH; Willekes M; van Roon E; Seslija L; Schneider P; Pieters R; Stam RW
    Cell Cycle; 2014; 13(5):834-44. PubMed ID: 24736461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities.
    Stoskus M; Gineikiene E; Valceckiene V; Valatkaite B; Pileckyte R; Griskevicius L
    Blood Cells Mol Dis; 2011 Apr; 46(4):321-6. PubMed ID: 21414819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
    Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
    Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC.
    Ennajdaoui H; Howard JM; Sterne-Weiler T; Jahanbani F; Coyne DJ; Uren PJ; Dargyte M; Katzman S; Draper JM; Wallace A; Cazarez O; Burns SC; Qiao M; Hinck L; Smith AD; Toloue MM; Blencowe BJ; Penalva LO; Sanford JR
    Cell Rep; 2016 May; 15(9):1876-83. PubMed ID: 27210763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of LIN28B-induced hematopoietic reprogramming by IGF2BP3.
    Wang S; Chim B; Su Y; Khil P; Wong M; Wang X; Foroushani A; Smith PT; Liu X; Li R; Ganesan S; Kanellopoulou C; Hafner M; Muljo SA
    Genes Dev; 2019 Aug; 33(15-16):1048-1068. PubMed ID: 31221665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-binding protein PUM2 promotes T-cell acute lymphoblastic leukemia via competitively binding to RBM5 3'UTR with miR-28-5p.
    Bai T; Liu N
    Eur J Haematol; 2023 May; 110(5):498-509. PubMed ID: 36536516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
    Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
    Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting IGF2BP3 enhances antileukemic effects of menin-MLL inhibition in MLL-AF4 leukemia.
    Lin TL; Jaiswal AK; Ritter AJ; Reppas J; Tran TM; Neeb ZT; Katzman S; Thaxton ML; Cohen A; Sanford JR; Rao DS
    Blood Adv; 2024 Jan; 8(2):261-275. PubMed ID: 38048400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncofetal protein IGF2BP3 facilitates the activity of proto-oncogene protein eIF4E through the destabilization of EIF4E-BP2 mRNA.
    Mizutani R; Imamachi N; Suzuki Y; Yoshida H; Tochigi N; Oonishi T; Suzuki Y; Akimitsu N
    Oncogene; 2016 Jul; 35(27):3495-502. PubMed ID: 26522719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WTAP/IGF2BP3-mediated GBE1 expression accelerates the proliferation and enhances stemness in pancreatic cancer cells via upregulating c-Myc.
    Jin W; Yao Y; Fu Y; Lei X; Fu W; Lu Q; Tong X; Xu Q; Su W; Hu X
    Cell Mol Biol Lett; 2024 Jul; 29(1):97. PubMed ID: 38961325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focused CRISPR-Cas9 genetic screening reveals USO1 as a vulnerability in B-cell acute lymphoblastic leukemia.
    Jaiswal AK; Truong H; Tran TM; Lin TL; Casero D; Alberti MO; Rao DS
    Sci Rep; 2021 Jun; 11(1):13158. PubMed ID: 34162911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.
    Li XX; Shi L; Zhou XJ; Wu J; Xia TS; Zhou WB; Sun X; Zhu L; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2017 Apr; 36(1):49. PubMed ID: 28399911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-196b/miR-1290 participate in the antitumor effect of resveratrol via regulation of IGFBP3 expression in acute lymphoblastic leukemia.
    Zhou W; Wang S; Ying Y; Zhou R; Mao P
    Oncol Rep; 2017 Feb; 37(2):1075-1083. PubMed ID: 28000876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global analysis of RNA-binding proteins identifies a positive feedback loop between LARP1 and MYC that promotes tumorigenesis.
    Desi N; Tong QY; Teh V; Chan JJ; Zhang B; Tabatabaeian H; Tan HQ; Kapeli K; Jin W; Lim CY; Kwok ZH; Tan HT; Wang S; Siew BE; Lee KC; Chong CS; Tan KK; Yang H; Kappei D; Yeo GW; Chung MCM; Tay Y
    Cell Mol Life Sci; 2022 Feb; 79(3):147. PubMed ID: 35195778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZFP36L1 promotes monocyte/macrophage differentiation by repressing CDK6.
    Chen MT; Dong L; Zhang XH; Yin XL; Ning HM; Shen C; Su R; Li F; Song L; Ma YN; Wang F; Zhao HL; Yu J; Zhang JW
    Sci Rep; 2015 Nov; 5():16229. PubMed ID: 26542173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
    Nandakumar SK; Johnson K; Throm SL; Pestina TI; Neale G; Persons DA
    Exp Hematol; 2015 Jul; 43(7):565-77.e1-10. PubMed ID: 25907033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
    Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
    Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.